LPL Financial
VNDA icon

LPL Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

LPL Financial’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.7K Buy
+15,805
New +$103K ﹤0.01% 5920
2014
Q2 		– Sell
-15,200
Closed -$247K – 2752
2014
Q1 		$247K Buy
+15,200
New +$216K ﹤0.01% 2281

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's VNDA Position: Q2 2026 in Review

LPL Financial opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 15,805 shares worth $96.7K. The stake represents ﹤0.01% of the portfolio and ranks #5920 among its holdings. This is a return to the name: LPL Financial previously reported a position in VNDA as recently as Q1 2014.

LPL Financial first reported a position in VNDA in Q1 2014 and has held it in 2 quarters since. The position peaked at $247K in Q1 2014. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • LPL Financial held 15,805 shares of Vanda Pharmaceuticals worth $96.7K as of Q2 2026.
  • Vanda Pharmaceuticals was a new LPL Financial position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5920 holding.
  • LPL Financial first reported a position in Vanda Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • LPL Financial's Vanda Pharmaceuticals position peaked at $247K in Q1 2014.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.